BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31323301)

  • 1. 8 years post-marketing surveillance between Asari Radix and hepatocellular carcinoma: Nationwide population-based evidence against an association.
    Chen CN; Tsai YT; Lai JN
    J Ethnopharmacol; 2019 Oct; 243():112094. PubMed ID: 31323301
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Fang ZE; Guo Y; Wang Z; He T; Wang J; Bai Z; Xiao X
    Chin Herb Med; 2022 Jul; 14(3):470-475. PubMed ID: 36117998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
    Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
    Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on morphology and aristolochic acid analogue constituents of Asarum campaniflorum and a comparison with two official species of Asari radix et rhizoma.
    Li YL; Tian M; Yu J; Shang MY; Cai SQ
    J Nat Med; 2010 Oct; 64(4):442-51. PubMed ID: 20640524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B and C viruses and survival from hepatocellular carcinoma in the Arkhangelsk region: a Russian registry-based study.
    Makarova M; Krettek A; Valkov MY; Grjibovski AM
    Int J Circumpolar Health; 2013; 72():20282. PubMed ID: 23687637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antinociceptive and anti-inflammatory potential and pharmacokinetic study of significant alkamides ingredients from Asarum Linn.
    Liu H; Li S; Huan X; Xie Y; Xie Z; Sun Y; Cao N; Xie Q; Wang Y; Wang H; Cheng X; Guan H; Wang C
    J Ethnopharmacol; 2022 Oct; 297():115569. PubMed ID: 35868550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herbal medicine containing aristolochic acid and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection.
    Chen CJ; Yang YH; Lin MH; Lee CP; Tsan YT; Lai MN; Yang HY; Ho WC; Chen PC;
    Int J Cancer; 2018 Oct; 143(7):1578-1587. PubMed ID: 29667191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The volatile components of three radix et rhizoma asari].
    Chen B; Hu SY; Li KW; Cui LJ; Yang JX
    Zhong Yao Cai; 2010 Dec; 33(12):1886-93. PubMed ID: 21548367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in incidence of hepatocellular carcinoma after diagnosis of hepatitis B or C infection: a population-based cohort study, 1992-2007.
    Thein HH; Walter SR; Gidding HF; Amin J; Law MG; George J; Dore GJ
    J Viral Hepat; 2011 Jul; 18(7):e232-41. PubMed ID: 21692938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa.
    Kirk GD; Lesi OA; Mendy M; Akano AO; Sam O; Goedert JJ; Hainaut P; Hall AJ; Whittle H; Montesano R
    Hepatology; 2004 Jan; 39(1):211-9. PubMed ID: 14752840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular carcinoma in individuals with HBV infection or HBV-HCV co-infection in a low endemic country.
    Davídsdóttir L; Duberg AS; Törner A; Aleman S; Bäck E; Ekdahl K; Blaxhult A; Ekbom A; Hultcrantz R
    Scand J Gastroenterol; 2010 Aug; 45(7-8):944-52. PubMed ID: 20384529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous determination of twenty-two components in Asari Radix et Rhizoma by ultra performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry.
    Wen H; Gao HY; Qi W; Xiao F; Wang LL; Wang D; Yuan D
    Planta Med; 2014 Dec; 80(18):1753-62. PubMed ID: 25513865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutual confounding and interactive effects between hepatitis C and hepatitis B viral infections in hepatocellular carcinogenesis: a population-based case-control study in Taiwan.
    Sun CA; Farzadegan H; You SL; Lu SN; Wu MH; Wolfe L; Hardy W; Huang GT; Yang PM; Lee H; Chen CJ
    Cancer Epidemiol Biomarkers Prev; 1996 Mar; 5(3):173-8. PubMed ID: 8833617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma in Egyptians with and without a history of hepatitis B virus infection: association with hepatitis C virus (HCV) infection but not with (HCV) RNA level.
    Yates SC; Hafez M; Beld M; Lukashov VV; Hassan Z; Carboni G; Khaled H; McMorrow M; Attia M; Goudsmit J
    Am J Trop Med Hyg; 1999 Apr; 60(4):714-20. PubMed ID: 10348253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Identification based on HPLC and anti-inflammatory targets as well as related constituents analysis of Asarum heterotropoides var. mandshuricum and A. sieboldii].
    Liu J; Liu GX; Shang MY; Xu F; Li YL; Zhou YZ; Xie DM; Wang X; Cai SQ
    Zhongguo Zhong Yao Za Zhi; 2020 Mar; 45(6):1374-1383. PubMed ID: 32281351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H1-Antihistamines Reduce the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus, Hepatitis C Virus, or Dual Hepatitis B Virus-Hepatitis C Virus Infection.
    Shen YC; Hsu HC; Lin TM; Chang YS; Hu LF; Chen LF; Lin SH; Kuo PI; Chen WS; Lin YC; Chen JH; Liang YC; Chang CC
    J Clin Oncol; 2022 Apr; 40(11):1206-1219. PubMed ID: 35044851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Qualitative and quantitative analysis of dodecatetraenamides A, B in Asari Radix et Rhizoma].
    Xie DM; Liu GX; Xu F; Shang MY; Zhang ZW; Wang X; Cai SQ
    Zhongguo Zhong Yao Za Zhi; 2015 Feb; 40(4):691-9. PubMed ID: 26137692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures.
    Tanaka M; Katayama F; Kato H; Tanaka H; Wang J; Qiao YL; Inoue M
    J Epidemiol; 2011; 21(6):401-16. PubMed ID: 22041528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coinfection of hepatitis B and C viruses and risk of hepatocellular carcinoma: systematic review and meta-analysis.
    Cho LY; Yang JJ; Ko KP; Park B; Shin A; Lim MK; Oh JK; Park S; Kim YJ; Shin HR; Yoo KY; Park SK
    Int J Cancer; 2011 Jan; 128(1):176-84. PubMed ID: 20232388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediagnostic concentrations of circulating bile acids and hepatocellular carcinoma risk: REVEAL-HBV and HCV studies.
    Petrick JL; Florio AA; Koshiol J; Pfeiffer RM; Yang B; Yu K; Chen CJ; Yang HI; Lee MH; McGlynn KA
    Int J Cancer; 2020 Nov; 147(10):2743-2753. PubMed ID: 32406072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.